EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Virtual Screening and Molecular Dynamics of Cytokine–Drug Complexes for Atherosclerosis Therapy

María Angélica Rodríguez-Fernández iD, Fabiola Estefanía Tristán-Flores, Diana Casique-Aguirre iD, María de la Luz Xochilt Negrete-Rodríguez iD, Juan Antonio Cervantes-Montelongo iD, Eloy Conde-Barajas iD, Gerardo Acosta-García iD, Guillermo Antonio Silva-Martínez iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26072931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von María Angélica Rodríguez-Fernández und 7 weiteren Autor:innen. Beteiligte Einrichtung: Posgrado de Ingeniería Bioquímica, Tecnológico Nacional de México/IT de Celaya, Celaya 38010, Guanajuato, Mexico. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Atherosclerosis, Cytokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, Seretaria de Ciencias, Humanidades, Tecnologías e Inovacion (SECIHTI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease remains the leading global cause of mortality, largely driven by atherosclerosis, a chronic inflammatory condition characterized by lipid accumulation and immune-cell infiltration in arterial walls. Macrophages play a central role by forming foam cells and secreting pro-atherogenic cytokines, such as TNF-α, IFN-γ, and IL-1β, which destabilize atherosclerotic plaques, expanding the lipid core and increasing the risk of thrombosis and ischemia. Despite the significant health burden of subclinical atherosclerosis, few targeted therapies exist. Current treatments, including monoclonal antibodies, are limited by high costs and immunosuppressive side effects, underscoring the urgent need for alternative therapeutic strategies. In this study, we employed in silico drug repositioning to identify multitarget inhibitors against TNF-α, IFN-γ, and IL-1β, leveraging a virtual screening of 2750 FDA-approved drugs followed by molecular dynamics simulations to assess the stability of selected cytokine–ligand complexes. This computational approach provides structural insights into potential inhibitors. Additionally, we highlight nutraceutical options, such as fatty acids (oleic, linoleic and eicosapentaenoic acid), which exhibited strong and stable interactions with key cytokine targets. Our study suggests that these bioactive compounds could serve as effective new therapeutic approaches for atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationAtherosclerosisCytokinesHumansDrug RepositioningTumor Necrosis Factor-alphaMolecular Docking SimulationInterferon-gammaInterleukin-1beta

Stichwörter der Autor:innen

atherosclerosiscytokine-targeted therapyfoam cellsmolecular dynamicspro-atherogenic cytokinesvirtual screening

Substanzen

CytokinesTumor Necrosis Factor-alphaInterferon-gammaInterleukin-1beta

Autor:innen und Institutionen

  • Posgrado de Ingeniería Bioquímica, Tecnológico Nacional de México/IT de Celaya, Celaya 38010, Guanajuato, Mexico.
  • Departamento de Ciencias Básicas, Tecnológico Nacional de México/IT de Celaya, Celaya 38010, Guanajuato, Mexico.
  • Laboratorio de Citómica del Cáncer Infantil, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Delegación Puebla, Puebla 06600, Mexico.
  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Ciudad de México 03940, Mexico.
  • Departamento de Ingeniería Bioquímica y Ambiental, Tecnológico Nacional de México/IT de Celaya, Celaya 38010, Guanajuato, Mexico.
  • Escuela de Medicina, Universidad de Celaya, Celaya 38080, Guanajuato, Mexico.

ORCID-Profile: María Angélica Rodríguez-Fernández, Diana Casique-Aguirre, María de la Luz Xochilt Negrete-Rodríguez, Juan Antonio Cervantes-Montelongo, Eloy Conde-Barajas, Gerardo Acosta-García, Guillermo Antonio Silva-Martínez

Förderung

  • Consejo Nacional de Humanidades, Ciencias y Tecnologías
  • Seretaria de Ciencias, Humanidades, Tecnologías e Inovacion (SECIHTI)

Zitieren

APA

Rodríguez-Fernández, M. A., Tristán-Flores, F. E., Casique-Aguirre, D., Negrete-Rodríguez, M. L. X., Cervantes-Montelongo, J. A., Conde-Barajas, E., Acosta-García, G., & Silva-Martínez, G. A. (2025). Virtual Screening and Molecular Dynamics of Cytokine–Drug Complexes for Atherosclerosis Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26072931

Vancouver

Rodríguez-Fernández MA, Tristán-Flores FE, Casique-Aguirre D, Negrete-Rodríguez MLX, Cervantes-Montelongo JA, Conde-Barajas E, et al. Virtual Screening and Molecular Dynamics of Cytokine–Drug Complexes for Atherosclerosis Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26072931

BibTeX
@article{RodrguezFernndez2025,
  author = {Rodríguez-Fernández, María Angélica and Tristán-Flores, Fabiola Estefanía and Casique-Aguirre, Diana and Negrete-Rodríguez, María de la Luz Xochilt and Cervantes-Montelongo, Juan Antonio and Conde-Barajas, Eloy and Acosta-García, Gerardo and Silva-Martínez, Guillermo Antonio},
  title = {Virtual Screening and Molecular Dynamics of Cytokine–Drug Complexes for Atherosclerosis Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26072931}
}
Kostenlos starten →